IMR Press / FBL / Volume 14 / Issue 6 / DOI: 10.2741/3374

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Article
Role of phosphoinositide 3-kinases in regulating cardiac function
Show Less
1 Baker IDI Heart and Diabetes Institute, Melbourne Victoria, 8008, Australia
2 Faculty of Medicine, Nursing, and Health Sciences, Department of Medicine (Alfred Hospital), Monash University, Victoria, 3181, Australia
3 Faculty of Medicine, Dentistry, and Health Sciences, Department of Biochemistry and Molecular Biology, University of Melbourne, Victoria, 3010, Australia
Front. Biosci. (Landmark Ed) 2009, 14(6), 2221–2229; https://doi.org/10.2741/3374
Published: 1 January 2009
Abstract

Phosphoinositide 3-kinases (PI3Ks) are important signaling proteins in the heart. Class IA PI3Ks (p110α, β) are critical regulators of physiological heart growth and cell survival, and are generally considered to be beneficial for heart function. In contrast, activation of class IB PI3K(p110γ) is detrimental for heart function, reducing cardiac contractility. This may have implications for the treatment of heart disease and failure. In vitro, ex vivo and in vivo studies have contributed to our understanding of PI3K signaling in the heart. This review summarizes class I PI3K signaling in the regulation of cardiac function, with a particular focus on the role of different PI3K isoforms in settings of heart disease.

Share
Back to top